Last updated: March 23, 2022
Sponsor: University of North Carolina, Chapel Hill
Overall Status: Completed
Phase
N/A
Condition
Coronary Artery Disease
Chest Pain
Heart Defect
Treatment
N/AClinical Study ID
NCT04131816
18-2540
Ages 40-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Individuals are eligible for the HeartHome study if they meet all the following inclusioncriteria:
- Diagnosed with one of the following conditions: myocardial infarction (MI)/acutecoronary syndrome (ACS), ST-elevation myocardial infarction (STEMI), non-STEMI,percutaneous coronary intervention (PCI) or stable angina;
- Decline traditional cardiac rehab or do not respond to traditional cardiac rehabenrollment methods;
- Willing to have a nurse visit them in their home and receive follow-up phone calls andtext messages for a 12-week intervention period;
- Understand the requirements of participation in and consent to the HeartHome program;
- Live within a 75-mile radius of the study site. Individuals are not eligible for the HeartHome study if they meet any of the following
Exclusion
exclusion criteria:
- Diagnosis of heart failure
- Diagnosis of valvular heart disease
- Presence of cardiac disease requiring surgery or other invasive procedure
- Impaired mental capacity resulting in an inability to understand or follow directionsand study protocol
- Impaired functional abilities that prevent them from participating in physicalactivity
- Presence of any serious medical conditions that are likely to cause premature death orto impair functional capacity
- No access to a telephone
Study Design
Total Participants: 14
Study Start date:
November 10, 2019
Estimated Completion Date:
February 11, 2022
Study Description
Connect with a study center
UNC Health Care
Chapel Hill, North Carolina 27514
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.